Joltoo
InvestorsInsights
DeepTech 2026 Playbook
Browse all
  1. Home
  2. /Investors
  3. /Biotech
  4. /Novartis Venture Fund
Novartis Venture Fund

Novartis Venture Fund

GeneralistBasel, SwitzerlandActiveWebsite
Stage FocusSeed, Series A, Series B+
GeographyUS, Europe
TypeCVC
Last Activity2026
Industry Focus
Industries
BiotechMedTech
Technical BenchStrong
Investor TypeCVC
ExposureMostly DeepTech Investments
Bio

The Novartis Venture Fund was founded in 1996, making it one of the oldest pharma CVCs still operating. With $750M+ in committed capital, the fund maintains a portfolio of 40+ active investments from a total of 163 over 25+ years.

Check sizes start at $100K and can reach $30-50M per company over the investment lifetime. The track record includes 24 IPOs and 62 acquisitions. Dual offices in Basel ...

Notable Investments
O
Omeros
A
Annexon
I
Icebreaker Health

Similar Funds

Pfizer Ventures

Pfizer Ventures

New York, United States

GeneralistBiotechMedTechSeedSeries A
Roche Venture Fund

Roche Venture Fund

Basel, Switzerland

GeneralistBiotechMedTechSeedSeries A
Sanofi Ventures

Sanofi Ventures

Paris, France

GeneralistBiotechMedTechSeedSeries A
Abingworth

Abingworth

London, United Kingdom

DeepTech NativeBiotechMedTechSeedSeries A
Brandon Capital

Brandon Capital

Melbourne, Australia

DeepTech NativeBiotechMedTechSeedSeries A
Leaps by Bayer

Leaps by Bayer

Leverkusen, Germany

DeepTech NativeBiotechAgriTechMedTechSeedSeries A
Joltoo
Privacy PolicyTerms of Service
© 2026 Joltoo. All rights reserved.